Guidance
Software, Inc. (NASDAQ: GUID), the World Leader in Digital
Investigations™, today announced a leading not-for-profit healthcare
organization has purchased a complete suite of EnCase products to gain
visibility into the location of sensitive patient information across its
network of over 100 locations serving more than 10,000 members.
According to a Ponemon Institute study, criminal attacks on healthcare
organizations have increased 100 percent since 2010.1 Using
EnCase, these organizations can locate and detect misuse of sensitive
data wherever it resides, collect evidence for legal proceedings, and
quickly and effectively respond to cyberattacks.
The U.S. Department of Health and Human Services estimates that
somewhere between 27.8 and 67.7 million people’s medical records have
been breached since 2009. The healthcare industry is under attack.
Reputations and patients are at risk, as well as compliance with the
Health Insurance Portability and Accountability Act (HIPAA) which
regulates the protection of the confidentiality and security of
healthcare information. EnCase provides a comprehensive approach to data
investigation, legal discovery automation, incident response, and
sensitive data discovery in a single suite of products to help mitigate
legal and security risks for organizations in healthcare and other
industries.
The organization first deployed EnCase®
Enterprise to meet internal investigations requirements. It then
expanded to use of EnCase®
eDiscovery to support litigation processes. Most recently, they
added EnCase®
Cybersecurity for incident response and sensitive data discovery,
allowing them to remediate security threats and locate patient
information stored on unauthorized devices. To further strengthen their
security posture, the company also invested in EnCase®
Analytics to look for signs of intrusion, locate malware, and
identify user policy violations across the organization’s systems.
“With greater access to healthcare services due to the Patient
Protection and Affordable Care Act (PPACA), more and more consumers are
entering the system, further burdening the resources of hospitals,
physicians and others that deal with very sensitive information,” said
Jay Ackerman, Chief Revenue Officer for Guidance Software. “Guidance
Software offers a powerful toolkit to address key security and legal
risks for industries under continuous scrutiny and threat, like the
healthcare sector, benefiting both the organizations and their patients.”
Consistently rated among the top performing health systems in their
region, the organization is using the following EnCase products:
-
EnCase Enterprise – The leading digital forensic tool for
remote investigations. It enables users to discreetly, accurately, and
securely access machines anywhere on their networks in order to
preview, collect, and examine digital evidence in a forensically sound
manner.
-
EnCase Analytics – An endpoint-based security analytics
solution that exposes signs of intrusion, behavioral anomalies, and
advanced threats across the enterprise.
-
EnCase Cybersecurity – An incident response product that
enables your security team to respond quickly to incoming threat
alerts to prioritize, investigate, and remediate incidents using
endpoint data for context.
-
EnCase eDiscovery – A market-leading and court-accepted
solution that automates Electronic Discovery Reference Model (EDRM)
workflows for legal and regulatory investigations, accelerates the
collection and preservation of ESI, and enables collaborative review
and production of evidence.
Guidance Software was named 2013 market share leader by Gartner for
Endpoint Detection and Response (EDR) tools in its November 2014
Competitive Landscape Report. Guidance Software has also been named a
“leader” in Gartner Inc.’s 2014 Magic Quadrant for e-discovery software,
in its fourth annual industry report.
1 2014 Ponemon Institute Benchmark Study on Patient Privacy
and Data Security, Page 2
About Guidance Software, Inc.
Guidance Software is recognized worldwide as the industry leader in
endpoint investigation solutions for security incident response,
e-discovery and forensic analysis. Its EnCase® Enterprise platform,
deployed on an estimated 25 million endpoints, is used by more than 70
percent of the Fortune 100, more than 45 percent of the Fortune 500, and
numerous government agencies to conduct digital investigations of
servers, laptops, desktops and mobile devices. Built on the EnCase
Enterprise platform are market-leading cybersecurity, IT help desk, and
electronic discovery solutions, EnCase® Cybersecurity, EnCase®
Analytics, EnCase® Remote Recovery + and EnCase® eDiscovery. They
empower organizations to conduct speedy and thorough security incident
response, reveal previously hidden security threats or malicious insider
activity, recover lost files, perform sensitive data discovery, and
respond to litigation discovery requests. For more information about
Guidance Software, visit www.encase.com.
EnCase®, EnScript®, FastBloc®, EnCE®, EnCEP®, Guidance Software™,
LinkedReview™, EnPoint™ and Tableau™ are registered trademarks or
trademarks owned by Guidance Software in the United States and other
jurisdictions and may not be used without prior written permission. All
other trademarks and copyrights referenced in this press release are the
property of their respective owners.
GUID-F
Copyright Business Wire 2015